SCHEMBL26327281

SCHEMBL26327281

CCCOC(=O)C(O)(O)C(=O)OCCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.41
ALDH1A1 P00352 6/20 0.40
LMNA P02545 2/20 0.39
TSHR P16473 2/20 0.38
CHRM1 P11229 2/20 0.38
ESR1 P03372 1/20 0.38
SLC6A2 P23975 1/20 0.38
KDR P35968 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ATM Q13315 1/20 0.34
NAAA Q02083 1/20 0.33
DGKA P23743 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33
PPM1B O75688 1/20 0.32
PTPN1 P18031 1/20 0.32
PPP1CC P36873 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4672467 0.82 HCAR2 (0.40) HCAR2ALDH1A1LMNATSHRCHRM1
SCHEMBL27984406 0.82 HCAR2 (0.40) HCAR2ALDH1A1LMNATSHRCHRM1
SCHEMBL20704238 0.80 HCAR2 (0.39) HCAR2ALDH1A1LMNATSHRCHRM1
SCHEMBL204763 0.79 POLB (0.44) HCAR2ALDH1A1LMNATSHRCHRM1
SCHEMBL6062638 0.79 HCAR2 (0.41) HCAR2ALDH1A1LMNATSHRCHRM1
SCHEMBL2251744 0.78 HCAR2 (0.38) HCAR2ALDH1A1LMNATSHRCHRM1
SCHEMBL14152314 0.78 HCAR2 (0.38) HCAR2ALDH1A1LMNATSHRCHRM1
SCHEMBL5491673 0.78 ALDH1A1 (0.50) ALDH1A1LMNATSHRATMKDM4E
SCHEMBL5610701 0.77 HCAR2 (0.45) HCAR2ALDH1A1LMNATSHRCHRM1
SCHEMBL5611304 0.77 HCAR2 (0.40) HCAR2ALDH1A1LMNATSHRCHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 HCAR2 4099/4885ALDH1A1 1805/4885LMNA 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.